CD80 and rheumatoid arthritis: The biologic abatacept has traditionally been used for the treatment of rheumatoid arthritis (RA) [57], where it acts as a T-cell inhibitor by binding to CD80 (B7-1) and CD86, thus blocking the costimulatory receptor CD28 [58].